Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant.
We have developed a new expression system based on the E. coli groEL promoter. The suicide vector constructed (called APC vector) allows simultaneous attenuation of a Salmonella strain by disruption of the coding sequence for aroA and stable integration of a gene into the bacterial chromosome. High-level expression of antigen is achieved after Salmonella is taken up by macrophages, a major antigen processing cell of the host. The chloramphenicol acetyltransferase (CAT) and the simian immunodeficiency virus capsid (p27gag) genes were cloned downstream of the groEL promoter and expressed within S. typhimurium. By measuring CAT activity, we showed that the groEL promoter was up-regulated during infection of the J774 macrophage line. The immune response to SIV capsid was assessed in Balb/c mice given one oral dose of vaccine. A local mucosal secretory IgA response against SIV capsid was detected but no systemic antibody response to the same antigen. A systemic CTL response was detected as early as 28 days to as late as 70 days post-immunization. CTL activity was MHC restricted (H-2d) and was mediated by CD3+, CD8+, CD4- T-lymphocytes. These results indicate that with only one oral dose of recombinant Salmonella using the APC vector, a systemic CTL response and a mucosal secretory response against the SIV capsid antigen are elicited in a mouse model.
Valentine
P J
PJ
Department of Microbiology and Immunology, Oregon Health Sciences University, Portland 97201, USA.
Meyer
K
K
Rivera
M M
MM
Lipps
C
C
Pauza
D
D
Maziarz
R T
RT
So
M
M
Heffron
F
F
D000818:Animals; D000942:Antigens, Bacterial / Q000096:biosynthesis / Q000276:immunology; D000956:Antigens, Viral / Q000096:biosynthesis / Q000276:immunology; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology / Q000494:pharmacology*; D001483:Base Sequence; D018834:Chaperonin 60 / Q000235:genetics; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D003001:Cloning, Molecular; D005260:Female; D015683:Gene Products, gag / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis* / Q000097:blood; D007413:Intestinal Mucosa / Q000276:immunology / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism / Q000382:microbiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009154:Mutation; D011401:Promoter Regions, Genetic / Q000235:genetics; D022562:Salmonella Vaccines; D012486:Salmonella typhimurium / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology*; D014436:Typhoid-Paratyphoid Vaccines
D000942:Antigens, Bacterial; D000956:Antigens, Viral; D001428:Bacterial Vaccines; D018834:Chaperonin 60; C066594:Gag protein p27, Simian immunodeficiency virus; D015683:Gene Products, gag; D007071:Immunoglobulin A, Secretory; D022562:Salmonella Vaccines; D014436:Typhoid-Paratyphoid Vaccines; C087350:aroA Salmonella vaccine; D015500:Chloramphenicol O-Acetyltransferase